New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. SPY
5. ACN
6. IBM
7. META
8. PFE
9. TSLA
10. DPZ

Go back to New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology
Gilead Sciences (NASDAQ: GILD) Delayed: 125.54 +0.67 (0.54%)
Previous Close $124.87    52 Week High $108.63 
Open $126.63    52 Week Low $71.39 
Day High $126.63    P/E 69.36 
Day Low $124.44    EPS $1.81 
Volume 2,416,135